Landmark study opens door to new cancer, aging treatments

Courtesy EurekAlert! - Cancer  Sat, 08/30/2008 - 23:00

(The Wistar Institute) Researchers at the Wistar Institute have deciphered the structure of the active region of telomerase, an enzyme that plays a major role in the development of nearly all human cancers.

The landmark achievement opens the door to the creation of new, broadly effective cancer drugs, as well as anti-aging therapies.

The study will be published online in Nature on Aug. 31.

Tags:

 

More related items

Long-Term Therapy Ineffective in Non-Responsive HCV
ST. LOUIS (MedPage Today) -- A landmark study of long-term peginterferon for patients with chronic hepatitis C that isn't responsive to therapy shows the extended treatment has no effect on...

Broccoli compound targets key enzyme in late-stage...
(University of California - Berkeley) Broccoli and other cruciferous vegetables have long been known to have anti-cancer benefits, and UC Berkeley researchers have now found out why. One...

Wistar scientists find key to keeping killer T cells...
(The Wistar Institute) Researchers at the Wistar Institute have found multiple receptors on the outside of the body's killer immune system cells which they believe can be selectively targeted...

NEW 2008 Paint It Black 50X Auto-Darkening Dark...
NEW FOR 2008!!! Unique Auto-Darkening Tan Technology delivers extreme dark bronze tanning results through its super luxurious silicone emulsion blend. Experience stunning dark tan color and...

IBS Audio Program 100 ~ For Irritable Bowel Syndrome...
The IBS Audio Program 100™, for Irritable Bowel Syndrome Self-Hypnosis, is the result of years of over 10 years of clinical research and experience by Michael Mahoney, the UK's leading...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com